Søren Bergenholt, CEO Alligator Bioscience at BioStock

Alligator Bioscience | Life Science Summit 2025

CEO Søren Bregenholt presents Alligator Bioscience at Life Science Summit 2025.

Video

Alligator Bioscience carries out rights issue of SEK 120 million

Alligator Bioscience granted US patent for ATOR-4066

Alligator presents phase I data at ESMO

Alligator publishes biomarker data from OPTIMIZE-1

Alligator Bioscience | Investing in Life Science 2025

CEO Søren Bregenholt presents Alligator Bioscience at Investing in Life Science 2025.

Video

Alligator Bioscience reports 92 percent utilization rate for TO 13

Alligator Bioscience reports 90,6 percent utilization rate for TO 13

Alligator presents preclinical data for ATOR-4066

Alligator publishes preclinical data for ATOR-4066

Alligator Bioscience renegotiates loan with Fenja Capital

New phase II/III study with Alligator's mitazalimab